Photocure ASA

Photocure ASA: Presentation of the third quarter 2018 results

Photocure will present its third quarter report on Thursday 8 November 2018 at

Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).

Representatives from the company will be Daniel Schneider, CEO, Erik Dahl, CFO

and Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial

Operations. Jan Egberts, Chairperson of Photocure ASA, will also be present. The

presentation will be held in English.

The quarterly report and presentation will be published at 07:00 CET and will be

publicly available at www.photocure.com. It will be possible to follow the

presentation through

http://webtv.hegnar.no/presentation.php?webcastId=97451491.

A light snack will be served from 08:00 (CET). The presentation is scheduled to

conclude at 09:15 (CET).

Please register your attendance to the presentations at Photocure by Wednesday 7

November.

Contact person: Tolv Hillestad (e-mail: [email protected] / phone +47 22 06 22

10).

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

Erik Dahl, CFO

Tel: +47 450 55 000

About Photocure ASA

Photocure, The Bladder Cancer Company, delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, which makes

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). The US headquarters for Photocure Inc., are in

Princeton, New Jersey. For more information, please visit us at

AI Terminal